Thyroid cancer constitutes a progressive continuum of disease ranging from indolent well-
differentiated carcinomas to aggressive poorly differentiated carcinomas and universally …

Clinical staging predicts tumor behavior in many cases, but does not allow true
'personalization'of initial therapy or identify potential therapeutic targets for patients with …

Molecular markers including gene expression profiles, somatic gene alterations, and
circulating peripheral markers have augmented diagnostic, prognostic, and therapeutic …

Thyroid tumorigenesis and molecular markers in thyroid cance... : Current Opinion in Oncology
Thyroid tumorigenesis and molecular markers in thyroid cancer : Current Opinion in Oncology …

There is now a reasonably good understanding of the key oncogenic events involved in the
initiation and progression of thyroid cancer. Many of these are characteristic of certain tumor …

Thyroid cancer is increasing in incidence. Although often indolent and highly curable
neoplasms, they may recur, metastasize, or become resistant to radio-iodine therapy …

Thyroid cancer represents the most common endocrine malignancy and its incidence is
increasing. The majority of thyroid tumours (90–95%) originate from the follicular epithelial …

Biologic and Clinical Perspectives on Thyroid Cancer | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

Thyroid cancer is a common endocrine malignancy. There has been exciting progress in
understanding its molecular pathogenesis in recent years, as best exemplified by the …

Conclusion Thyroid nodules are common and their management can be difficult and
controversial. Clearly, the pathologist has an important role to play in their evaluation. The …